Data from the TROPIC clinical trial was announced at the American Society of Clinical Oncology (ASCO) 2010 Genitourinary Cancer Symposium. This phase III study was conducted at 146 sites in 26 countries. CORT was the study site in …
The rest is here:
XRP6258 (Cabazitaxel) Increased Survival for Patients with …
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.